SAM
CGON icon

Smartleaf Asset Management’s CG Oncology CGON Stock Holding History

Smartleaf Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Hold
181
– – ﹤0.01% 2231
2026
Q1 		$11.6K Buy
181
+114
+170% +$6.46K ﹤0.01% 2245
2025
Q4 		$2.69K Buy
67
+55
+458% +$2.28K ﹤0.01% 2898
2025
Q3 		$468 Buy
12
+7
+140% +$204 ﹤0.01% 2867
2025
Q2 		$129 Buy
+5
New +$120 ﹤0.01% 2686

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Smartleaf Asset Management's CGON Position: Q2 2026 in Review

Smartleaf Asset Management held its CG Oncology (CGON) position steady in Q2 2026 at 181 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Smartleaf Asset Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Smartleaf Asset Management held 181 shares of CG Oncology worth $13.3K as of Q2 2026.
  • Smartleaf Asset Management left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2231 holding.
  • Smartleaf Asset Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.